Q32 Bio
QTTB
118 hedge funds and large institutions have $240M invested in Q32 Bio in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 16 reducing their positions, and 18 closing their positions.
213% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 16
50% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 18
8% more funds holding
Funds holding: 109 → 118 (+9)
0.02% more ownership
Funds ownership: 3.19% → 3.21% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
12% less capital invested
Capital invested by funds: $273M → $240M (-$33.1M)
69% less call options, than puts
Call options by funds: $322K | Put options by funds: $1.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.95M |
| 3 |
BlackRock
New York
|
+$3.42M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.37M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$7.53M |
| 2 |
Rafferty Asset Management
New York
|
-$4.31M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.96M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$887K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$743K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
126
Bridgefront Capital
Austin,
Texas
| – | -$120K | -707 | Closed |
|
|
HIIFS
127
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | -$314K | -556 | Closed |
|
|
MLICM
128
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$87.4K | -516 | Closed |
|
|
MIM
129
MetLife Investment Management
Whippany,
New Jersey
| – | -$30.2K | -178 | Closed |
|
130
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$8K | -60 | Closed |
|
|
CFGS
131
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$2.5K | -20 | Closed |
|
|
VFA
132
Valeo Financial Advisors
Carmel,
Indiana
| – | -$3K | -19 | Closed |
|
|
SPIA
133
Steward Partners Investment Advisory
New York
| – | -$2.54K | -15 | Closed |
|
|
SBL
134
Sargent Bickham Lagudis
Boulder,
Colorado
| – | -$1K | -6 | Closed |
|
|
PA
135
Parallel Advisors
San Francisco,
California
| – | +$125 | +1 | New |
|
QTTB Hedge Fund Activity: Q2 2021 in Review
118 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2021, worth a combined $240M — down 12% from $273M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new QTTB positions and 18 closed out — a net gain of 9 holders — while 50 added to existing stakes and 16 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $5.2M. The largest seller was JP Morgan Chase, cutting an estimated $7.53M.
- 118 institutional investors held Q32 Bio (QTTB) as of Q2 2021, up from 109 in Q1 2021.
- Funds reported $240M of Q32 Bio stock for Q2 2021, down 12% quarter-over-quarter.
- 27 funds opened new Q32 Bio positions in Q2 2021 and 18 closed out, a net change of +9 holders.
- The largest Q32 Bio buyer in Q2 2021 was Fidelity Investments, an estimated $5.2M added.
- The largest Q32 Bio seller in Q2 2021 was JP Morgan Chase, an estimated $7.53M sold.
Based on aggregated 13F filings for Q2 2021.